Treatment of exacerbations of chronic obstructive pulmonary disease


Cite item

Full Text

Abstract

Chronic obstructive pulmonary disease (COPD) and its exacerbations remain an important problem of clinical medicine. Aim. To assess the quality of medical care provided in large Russian hospitals to patients with COPD exacerbation. Materials and methods. The study included patients with acute exacerbations of COPD hospitalized into three large clinical hospitals in Moscow. The diagnosis of "COPD exacerbation" was established in accordance with current clinical recommendations. We collected the data about patients’ demography, clinical signs and symptoms, blood gas analysis, chest radiography, drug therapy, oxygen therapy and respiratory support. The follow-up period was 90 days. The obtained data were compared with the data of patients from the multicenter study "European COPD Audit". Results and discussion. The leading clinical symptoms in COPD exacerbation were dyspnea (95.4%) and sputum production (60.7%). The majority of patients with COPD received short-acting β2-agonists (77.4%), systemic steroids (85.1%), antibiotics (79.0%) and theophyllines (48.1%). Noninvasive ventilation was performed in 8.6% of patients, oxygen therapy - in 23,8% of patients, pulmonary rehabilitation - in only 6,2% of patients. Chest radiography was performed in 97.9% of patients, pulmonary function tests - in 79.8%, blood gases analysis - in 19.3% of patients. The mean duration of hospitalization was 18.2±3.9 days, repeated hospitalization within 90 days occurs in 36.2% of patients. In-hospital mortality was 3.3%. Conclusion. Based on the results of the study practical recommendations for improving the quality of medical care in acute exacerbations of COPD are proposed.

About the authors

S N Avdeev

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Pulmonology Research Institute of Federal Medico-Biological Agency of Russia

д.м.н., проф., член-корр. РАН, зав. каф. пульмонологии Первого МГМУ им. И.М. Сеченова, зам. директора по научной работе, зав. клиническим отд. НИИ пульмонологии Moscow, Russia

N V Truschenko

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Pulmonology Research Institute of Federal Medico-Biological Agency of Russia

к.м.н., ассистент каф. пульмонологии Первого МГМУ им. И.М. Сеченова, н.с. НИИ пульмонологии Moscow, Russia

V V Gaynitdinova

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Email: ivv_08@mail.ru
д.м.н., проф. каф. пульмонологии Первого МГМУ им. И.М. Сеченова Moscow, Russia

A K Soe

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

аспирант РНИМУ им. Н.И. Пирогова Moscow, Russia

G S Nuralieva

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Pulmonology Research Institute of Federal Medico-Biological Agency of Russia

к.м.н., ассистент каф. пульмонологии Первого МГМУ им. И.М. Сеченова; н.с. НИИ пульмонологии Moscow, Russia

References

  1. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. Пульмонология. 2014;(3):15-54
  2. Global strategy for the diagnosis, management and prevention of COPD. Available from: https://goldcopd.org/gold-reports, 2018.
  3. Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchali A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M. Russian experience of creating clinical COPD guidelines and a clinical decision making algorithm. Int J COPD. 2018;13:183-7. doi: 10.2147/COPD.S153770
  4. WHO: Chronic obstructive pulmonary disease (COPD). 2016. Available from: http://www.who.int/topics/chronic_obstructive_pulmonary_disease/en/
  5. GBD 2015 Mortality and causes of death collaborators: global, regional and national life expectancy, all - causes mortality and cause - specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global burden of disease study 2015. Lancet. 2016;388:1459-544. doi: 10.1016/S0140-6736(16)31012-1
  6. Husebo G.R, Bakke P.S, Aanerud M, Hardie J.A, Ueland T et al. Predictors of exacerbations in chronic obstructive pulmonary disease - results from the Bergen COPD cohort study. PLoS One. 2014;9:e109721. doi: 10.1371/journal.pone.0109721
  7. Self T.H, Patterson S.J, Headley A.S, Finch C.K. Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations: focus on oral corticostaroids. Curr Med Res Opin. 2014;30:2607-15. doi: 10.1159/000477911
  8. Connors A.F.Jr, Dawson N.V, Thomas C, Harrell F.E.Jr, Desbiens N, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risk Treatments). Am J Respir Crit Care Med. 1996;154:959-67. doi: 10.1164/ajrccm.154.4.8887592
  9. Tokgoz Akyil F, Gunen H, Agca M, Gungor S, Yalcinsoy M, Sucu P, Akyil M, Sevim T. Patient outcome after chronic obstructive pulmonary disease exacerbations requiring noninvasive ventilation during hospitalization. Arch Bronconeumol. 2016;52(9):470-6. doi: 52:470-476.10.1016/j.arbres.2016.01.021
  10. Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011;9:7. doi: 10.1186/1741-7015-9-7
  11. Rochwerg B, Brochard L, Elliott M.W, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Resp J. 2017;50:1602426. doi: 10.1183/13993003.02426-2016
  12. Hartl S. The European COPD Audit: a pilot experience of 16 European countries. Pneumonol Alergol Pol. 2012;80:501-4.
  13. López-Campos J.L, Hartl S, Pozo-Rodríguez F, Roberts C.M. European COPD Audit Team European COPD Audit: design, organization of work and methodology. Eur Respir J. 2013;41:270-6. doi: 10.1183/09031936.00021812
  14. Roberts C.M, López-Campos J.L, Pozo-Rodríguez F, Hartl S. European COPD Audit Team European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax. 2013;68:1169-71. doi: 10.1136/thoraxjnl-2013-203465
  15. British Thoracic Society Standards of Care Committee; Non - invasive ventilation in acute respiratory failure. Thorax. 2002;57:192-211. doi: 10.1136/thorax.57.3.192
  16. Авдеев С.Н. Неинвазивная вентиляция легких у пациентов c хронической обструктивной болезнью легких в стационаре и домашних условиях. Пульмонология. 2017;27(2):232-49 doi: 10.18093/0869-0189-2017-27-2-232-249
  17. Wedzicha J.A, Miravitles M, Hurst J.R, Calverley P.M, Albert R.K, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49:1600791. doi: 10.1183/13993003.00791-2016
  18. Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta - analysis. Clin Infect Dis. 2012;55:651-62. doi: 10.1093/cid/cis464
  19. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al. Antibiotic treatment of exacerbations of COPD; a randomized, controlled trial comparing procalcitonin - guidance with standard therapy. Chest. 2007;131:9-19. doi: 10.1378/chest.06-1500
  20. Ford P.A, Durham A.L, Russell R.E, Gordon F, Adcock I.M. Treatment effects of low - dose theophylline combined with an inhaled corticosteroid in COPD. Chest. 2010;137:1338-44. doi: 10.1378/chest.09-2363
  21. Zhang W.H, Zhang Y, Cui Y.Y, Rong W.F, Cambier C, et al. Can β2-adrenoreceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD? Fundam Clin Pharmacol. 2012;26:118-34. doi: 10.1111/j.1472-8206.2011.01007.x
  22. Yawn B.P. Is “GOLD” standard for the management of COPD in clinical practice? Drugs Context. 2012;2012:212-34. doi: 10.7573/dic.212243
  23. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390-413. doi: 10.1164/rccm.200508-1211ST
  24. Puhan M.A, Gimeno-Santos E, Scharplatz M, Troosters T, Walters E.H, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;10:CD005305. doi: 10.1002/14651858.CD005305.pub3
  25. Osthoff M, Leuppi J.D. Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration. 2010;79:255-61. doi: 10.1159/000235721
  26. Мещерякова Н.Н. Принципы легочной реабилитации больных хронической обструктивной болезнью легких. Атмосфера. Пульмонология и аллергология. 2013;49:27-31
  27. Saleh A, Lopez-Campos J.L, Hartl S, Pozo-Rodriguez F, Roberts C.M. European COPD Audit Team: The effect of incidental consolidation on management and outcomes in COPD exacerbation: data from the European COPD Audit. PLoS One. 2015;10:0134004. doi: 10.1183/09031936.00021812
  28. Poole P.J, Chacko E, Wood-Baker R.W, Cates C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;1:CD002733. doi: 10.1002/14651858.CD002733.pub2
  29. Van Eerd E.A, van der Meer R.M, van Schayk O.C, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;8:CD010744. doi: 10.1002/14651858.CD010744.pub2
  30. Kelly A.M, Mc Alpine R, Kyle E. How accurate are pulse oximeters in patientswith acute exacerbationsof chronic obstructive airways disease? Respir Med. 2001;95(5):336-40. doi: 10.1053/rmed.2001.1046
  31. Malatesha G, Singh N.K, Bharija A, Rehani B, Goel A. Comparison of arterial and venous pH, bicarbonate, PCO2 and PO2 initial emergency department assessment. Emerg Med J. 2007;24:569-71. doi: 10.1136/emj.2007.046979
  32. Bloom B.M, Grudlingh J, Bestwick J.P, Harris T. The role of venous blood gas in the emergency department: a systematic review and meta - analysis. Eur J Emerg Med. 2014;21:81-8. doi: 10.1097/MEJ.0b013e32836437cf
  33. Rea H, Kenealy T, Adair J, Robinson E, Sheridan N. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2011;6:527-32. doi: 10.1186/1471-2466-12-73
  34. Hill K, Goldstein R.S, Guyatt G.H, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary diseaseamong patients at risk in primary care. CMAJ. 2010;182:673-8. doi: 10.1503/cmaj.091784
  35. Higgings B.G, Powell R.M, Cooper S, Tattersfield A.E. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J. 1991;4:415-20.
  36. O’Driscoll B.R, Kay E.A, Taylor R.J, Weatherby H, Chetty M.C, Bernstein A. A long - term prospective assessment of home nebulizer treatment. Respir Med. 1992;86:317-25.
  37. Barnes P.J. Theophylline. Am J Respir Crit Care Med. 2013;188:901-6. doi: 10.1164/rccm.201302-0388PP
  38. Rossi A, Kristufek P, Levine B.E, Thomson M.H, Till D, Kottakis J, et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow - release theophylline in the treatment of COPD. Chest. 2002;121:1058-69.
  39. Woods J.A, Wheeler J.S, Finch C.K, Pinner N.A. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:421-30. doi: 10.2147/COPD.S51012
  40. Leuppi J.D, Schuetz P, Bingisser R, Bodmer M, Briel M, et al. Short - term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013;309:2223-31. doi: 10.1001/jama.2013.5023
  41. Walters J.A, Tan D.J, White C.J, Gibson P.G, Wood-Baker R, Walters E.H. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;9:CD001288. doi: 10.1002/14651858.CD001288.pub4
  42. Walters J.A, Tan D.J. White C.J, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;12:CD006897. doi: 10.1002/14651858.CD006897.pub3
  43. Stefan M.S, Rothberg M.B, Shieh M.S, Pekow P.S, Lindenauer P.K. Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest. 2013;143:82-90. doi: 10.1378/chest.12-0649
  44. Vollenweider D.J, Jarrett H, Steurer-Stey C.A, Garcia-Aymerich J, Puhan M.A. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD010257. doi: 10.1002/14651858.CD010257
  45. Lindenauer P.K, Stefan M.S, Shieh M.S, Pekow P.S, Rothberg M.B, Hill N.S. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med. 2014;174:1982-93. doi: 10.1002/14651858.CD010257
  46. Olieveri C, Carenzo L, Vignazia G.L, Campanini M, Pirisi M, et al. Does noninvasive ventilation delivery in the ward provide early effective ventilation? Respir Care. 2015;60:6-11. doi: 10.4187/respcare.03294
  47. Ramsay M, Hart N. Current opinions on noninvasive ventilation as a treatment for chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2013;19:626-30. doi: 10.1097/MCP.0b013e3283659e4c
  48. Boldrini R, Fasano L, Nava S. Noninvasive mechanical ventilation. Curr Opin Crit Care. 2012;18:48-53. doi: 10.1097/MCC.0b013e32834ebd71
  49. Mehta S, Hill N.S. Noninvasive ventilation. Am J Respir Crit Care Med. 2001;163:540-77.
  50. Hartl S, Lopez-Campos J.L, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, et al. Risk of death and readmission of hospital admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016;47:113-21. doi: 10.1183/13993003.01391-2014
  51. Ries A.L, Bauldoff G.S, Carlin B.W, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131:4S-42S. doi: 10.1378/chest.06-2418

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies